The healthcare industry is evolving rapidly with the adoption of artificial intelligence (AI) in areas such as screening and diagnostics, drug and therapy, and administration. However, AI’s impact on the industry can only be maximized once expanded beyond single-point usecases to directly address outcome-focused patient care.
This white paper describes the transformative capabilities of Medical AI, a DeLorean AI (DAI) solution, piloted in seventeen (17) Innovative Renal Care (IRC) dialysis centers over a 3-month period. The following will highlight the AI solution’s capacity to predict missed treatments, hospitalizations due to fluid overload, as well as other key measures such as adequate clearance and anemia management. By integrating Medical AI into daily workflows of clinical staff, IRC improved patient outcomes, enhanced treatment adherence, and optimized resource allocation.
DeLorean Artificial Intelligence’s Medical AI has achieved demonstrable benefits after being deployed within IRC centers. Benefits include predicting missed treatments and upcoming hospitalizations, enhancing patient outcomes, and reducing healthcare costs. In addition to
direct use for managing patient risk at the point of care, results are also being used to inform treatment and care planning as well as Quality Assurance and Process Improvement (QAPI) retrospectives.